The United Laboratories International Holdings Limited (HKG:3933)
Hong Kong · Delayed Price · Currency is HKD 12.57
-0.13 (-1.02%)
Oct 30, 2025, 4:08 PM HKT
HKG:3933 Market Cap
HKG:3933 has a market cap or net worth of 25.06 billion as of October 30, 2025. Its market cap has increased by 21.17% in one year.
Market Cap
25.06B
Enterprise Value
20.85B
Revenue
15.45B
Ranking
n/a
PE Ratio
6.88
Stock Price
12.57
Market Cap Chart
Since June 15, 2007, HKG:3933's market cap has increased from 4.33B to 25.06B, an increase of 478.40%. That is a compound annual growth rate of 10.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 25.06B | 11.57% |
| Dec 31, 2024 | 22.46B | 76.32% |
| Dec 29, 2023 | 12.74B | 43.06% |
| Dec 30, 2022 | 8.90B | 11.62% |
| Dec 31, 2021 | 7.98B | -21.20% |
| Dec 31, 2020 | 10.12B | 8.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 269.73B |
| Hansoh Pharmaceutical Group Company | 209.22B |
| JD Health International | 199.13B |
| WuXi Biologics | 149.43B |
| Innovent Biologics | 144.96B |
| Sino Biopharmaceutical | 125.85B |
| Akeso | 105.01B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.36B |